Can Singulair (montelukast) and XYZAL (levocetirizine) be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Singulair and Xyzal Be Taken Together?

Yes, Singulair (montelukast) and Xyzal (levocetirizine) can be safely taken together, and this combination is more effective than montelukast alone for treating allergic rhinitis. The FDA drug label for Singulair explicitly confirms no clinically significant drug interactions exist between these medications 1.

Safety Profile

The combination is well-established as safe:

  • No pharmacokinetic interactions: Montelukast has been studied extensively with antihistamines and shows no clinically important effects on drug metabolism 1
  • Similar adverse event rates: Multiple studies demonstrate that combination therapy does not increase side effects compared to monotherapy, with only mild adverse events reported in approximately 14% of patients 2, 3
  • FDA-approved co-administration: The Singulair label specifically lists antihistamines among medications that can be used concomitantly without evidence of clinical adverse interactions 1

Clinical Efficacy Evidence

The montelukast-levocetirizine combination demonstrates superior symptom control compared to montelukast alone, particularly for:

Daytime Symptoms

  • Nasal congestion: Significantly greater improvement with combination therapy (p = 0.0341) 2
  • Rhinorrhea: Better control with combination (p = 0.0469) 2
  • Overall daytime symptoms: Standardized mean difference of -0.44 favoring combination 4

Nighttime Symptoms

  • Nasal congestion severity when awake: Greater reduction with combination (p = 0.0381) 2
  • Only the levocetirizine-based combination (not other antihistamines) shows significant nighttime benefit 5, 6

Quality of Life

  • RQLQ scores: Significantly improved with combination therapy (p < 0.0001) 2
  • Standardized mean difference of -0.48 favoring combination 4

Clinical Recommendation Algorithm

For patients with allergic rhinitis:

  1. Mild symptoms: Consider montelukast or levocetirizine monotherapy
  2. Moderate-to-severe symptoms: Use combination therapy as first-line treatment
  3. Predominant nasal congestion and rhinorrhea: Combination therapy is particularly beneficial 2, 6
  4. Nighttime symptoms: Combination specifically addresses nocturnal nasal congestion 2, 5
  5. Concurrent asthma: Combination may provide dual benefit for both conditions 7

Dosing

  • Adults and children ≥15 years: Montelukast 10 mg + levocetirizine 5 mg once daily
  • Children 6-14 years: Montelukast 5 mg + levocetirizine 5 mg once daily 2
  • Timing: Evening administration is standard for montelukast 1

Important Caveats

While guidelines suggest intranasal corticosteroids remain first-line for seasonal allergic rhinitis 8, the combination of montelukast and levocetirizine offers:

  • Oral convenience for patients who cannot tolerate or refuse intranasal medications
  • Comprehensive symptom control through dual mechanism (leukotriene and histamine blockade)
  • Fixed-dose combination formulations available to improve adherence 9

The combination is particularly valuable when intranasal corticosteroids are contraindicated, not tolerated, or when patients prefer oral therapy, though it should be recognized as less effective than intranasal corticosteroids for initial treatment of seasonal allergic rhinitis 8.

References

Research

Effect of inhaled corticosteroid with oral montelukast and levocetirizine in asthma: A population-based study.

International journal of clinical pharmacology and therapeutics, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.